| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5543d31bb935979cb022247bfbfb375b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 |
| filingDate |
2010-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71217a1ff5ccd82c11dbe4aa47f84252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8db3185deca7ab473490e3b04a93674 |
| publicationDate |
2011-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011160264-A1 |
| titleOfInvention |
Orally administrable film dosage forms containing ondansetron |
| abstract |
The invention relates to orally administrable, disintegrating film dosage forms which include ondansetron and methods of orally administering the film dosage forms. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2523565-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2015228545-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9675588-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10668050-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11304933-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015136377-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016004409-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9770409-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9636305-B2 |
| priorityDate |
2009-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |